Xtant Medical Holdings Inc. [AMEX: XTNT] jumped around 0.13 points on Tuesday, while shares priced at $1.60 at the close of the session, up 8.84%. The company report on August 10, 2020 that Xtant Medical Announces Debt Restructuring.
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has entered into a Restructuring and Exchange Agreement with the lenders under its credit facility pursuant to which the parties agreed to take certain actions to restructure Xtant’s outstanding indebtedness, including the exchange of certain indebtedness outstanding under the facility, together with accrued and unpaid interest thereon, into shares of Xtant common stock.
The primary purpose of the restructuring is to improve Xtant’s capital structure by reducing its outstanding debt, which the Company expects will facilitate future access to capital markets for investment in its growth initiatives, and provide a path to possibly regain compliance with the NYSE American continued listing standards.
Xtant Medical Holdings Inc. stock is now 0.00% down from its year-to-date (YTD) trading value. XTNT Stock saw the intraday high of $1.67 and lowest of $1.22 per share. The company’s 52-week high price is 3.50, which means current price is +190.91% above from all time high which was touched on 05/21/20.
Compared to the average trading volume of 1.41M shares, XTNT reached a trading volume of 2500233 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Xtant Medical Holdings Inc. [XTNT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XTNT shares is $1.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XTNT stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Xtant Medical Holdings Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 15, 2018. While these analysts kept the previous recommendation, Maxim Group dropped their target price from $18 to $10. The new note on the price target was released on February 14, 2018, representing the official price target for Xtant Medical Holdings Inc. stock.
The Average True Range (ATR) for Xtant Medical Holdings Inc. is set at 0.24, with the Price to Sales ratio for XTNT stock in the period of the last 12 months amounting to 0.36.
How has XTNT stock performed recently?
Xtant Medical Holdings Inc. [XTNT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 53.85. With this latest performance, XTNT shares gained by 72.06% in over the last four-week period, additionally plugging by 14.29% over the last 6 months – not to mention a drop of -46.67% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XTNT stock in for the last two-week period is set at 72.24, with the RSI for the last a single of trading hit 78.40, and the three-weeks RSI is set at 67.57 for Xtant Medical Holdings Inc. [XTNT]. The present Moving Average for the last 50 days of trading for this stock 1.0785, while it was recorded at 1.2660 for the last single week of trading, and 1.2443 for the last 200 days.
Xtant Medical Holdings Inc. [XTNT]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Xtant Medical Holdings Inc. [XTNT] shares currently have an operating margin of -3.48 and a Gross Margin at +65.64. Xtant Medical Holdings Inc.’s Net Margin is presently recorded at -12.71.
Return on Total Capital for XTNT is now -11.65, given the latest momentum, and Return on Invested Capital for the company is -43.64. Additionally, XTNT Total Debt to Total Capital is recorded at 242.34, with Total Debt to Total Assets ending up at 174.39.
Reflecting on the efficiency of the workforce at the company, Xtant Medical Holdings Inc. [XTNT] managed to generate an average of -$58,305 per employee. Receivables Turnover for the company is 6.43 with a Total Asset Turnover recorded at a value of 1.44.Xtant Medical Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 3.30.
Earnings analysis for Xtant Medical Holdings Inc. [XTNT]
With the latest financial reports released by the company, Xtant Medical Holdings Inc. posted -0.21/share EPS, while the average EPS was predicted by analysts to be reported at -0.36/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 41.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for XTNT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Xtant Medical Holdings Inc. go to 20.00%.
Insider trade positions for Xtant Medical Holdings Inc. [XTNT]
There are presently around $19 million, or 90.50% of XTNT stock, in the hands of institutional investors. The top three institutional holders of XTNT stocks are: ORBIMED ADVISORS LLC with ownership of 9,207,012, which is approximately 0% of the company’s market cap and around 6.40% of the total institutional ownership; PARK WEST ASSET MANAGEMENT LLC, holding 1,257,759 shares of the stock with an approximate value of $2.01 million in XTNT stocks shares; and TELEMETRY INVESTMENTS, L.L.C., currently with $1.2 million in XTNT stock with ownership of nearly -0.037% of the company’s market capitalization.
Positions in Xtant Medical Holdings Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 7 institutional holders increased their position in Xtant Medical Holdings Inc. [AMEX:XTNT] by around 214,957 shares. Additionally, 5 investors decreased positions by around 13,844 shares, while 9 investors held positions by with 11,826,032 shares. The mentioned changes placed institutional holdings at 12,054,833 shares, according to the latest SEC report filing. XTNT stock had 5 new institutional investments in for a total of 210,159 shares, while 1 institutional investors sold positions of 2,189 shares during the same period.